1. Shah VP, Besancon LJR, Stolk P, Tucker G, Crommelin DJA. The Pharmaceutical Sciences in 2020: Report of a conference organized by the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation (FIP). Int Pharm J. 2009;24(1):1–16.
2. Innovations—Stagnation. Challenges and opportunities on the critical path to new medical products, View from The U.S. Food and Drug Administration, March 2004 and Critical path opportunity report. US Department of Health and Human Services, FDA. March 2006.
3. European Medicines Agency Road Map to 2010: Preparing the ground for the future, March 2005; http://www.emea.europa.eu/pdfs/general/direct/directory/3416303enF.pdf .